逆势完成C1轮融资并开启C2轮融资，数问生物加速全球化市场布局

Core Viewpoint - Recently, Zhejiang Shuwen Biotechnology Co., Ltd. announced the completion of nearly 100 million C1 round financing and the initiation of C2 round financing, aimed at accelerating the promotion of its innovative diagnostic products and enhancing R&D investment in women's health [1][4]. Group 1: Financing and Investment - The C1 round financing was led by Jinchuang Investment, with existing shareholder Yuansheng Venture Capital continuing to invest [1]. - The funds will be used to promote the company's pioneering diagnostic products in domestic and international markets and to enrich its product pipeline in women's health [1]. Group 2: Product Development and Innovation - Shuwen Biotechnology focuses on the development, production, sales, and medical testing services of in vitro diagnostic reagents, particularly in women's health [1][5]. - The company has developed the world's first home self-test product for preeclampsia, CercaTestRED, and a urine rapid test product, Wenxian'an, which allows pregnant women to screen for preeclampsia at home [2]. - In the breast cancer field, the company has created over ten detection products covering the entire disease course, providing comprehensive solutions for precision medicine, companion diagnostics, and monitoring [2]. Group 3: Global Market Expansion - The company has made significant progress in global market expansion, collaborating with major distributors like Sysmex to promote EU-certified products in nearly 50 countries [3]. - In Europe, the company's subsidiary in Germany promotes its first-in-class products, with MammaTyper included in breast cancer treatment guidelines in Spain and endorsed by the president of Burkina Faso for national use [3]. - Shuwen Biotechnology is also pursuing registrations for innovative home and rapid testing products in the U.S. and EU, as well as entering new drug development and companion diagnostics [3]. Group 4: Future Prospects - The company has initiated a new round of strategic cooperation and financing negotiations to gain more resources and opportunities for global innovation and development in women's health [4]. - Shuwen Biotechnology aims to continue its innovative spirit and launch more high-quality diagnostic products, contributing significantly to women's health [4].